{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T09:02:02Z","timestamp":1792746122119,"version":"4.5.0"},"publisher-location":"New York, NY","reference-count":105,"publisher":"Springer New York","isbn-type":[{"value":"9781493978243","type":"print"},{"value":"9781493978250","type":"electronic"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/978-1-4939-7825-0_6","type":"book-chapter","created":{"date-parts":[[2018,5,31]],"date-time":"2018-05-31T08:44:16Z","timestamp":1527756256000},"page":"97-120","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":73,"title":["Mouse Models of Huntington\u2019s Disease"],"prefix":"10.1007","author":[{"given":"Pamela P.","family":"Farshim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian P.","family":"Bates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,1]]},"reference":[{"key":"6_CR1","volume-title":"Huntington\u2019s disease","author":"G Bates","year":"2014","unstructured":"Bates G, Tabrizi S, Jones L (2014) Huntington\u2019s disease, vol 64. Oxford University Press, Oxford, UK"},{"key":"6_CR2","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","volume":"44","author":"J-P Vonsattel","year":"1985","unstructured":"Vonsattel J-P, Myers RH, Stevens TJ et al (1985) Neuropathological classification of Huntington\u2019s disease. J Neuropathol Exp Neurol 44:559\u2013577","journal-title":"J Neuropathol Exp Neurol"},{"key":"6_CR3","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"ME Macdonald","year":"1993","unstructured":"Macdonald ME, Ambrose CM, Duyao MP et al (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntingtons-disease chromosomes. Cell 72:971\u2013983","journal-title":"Cell"},{"key":"6_CR4","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.brainresbull.2011.07.009","volume":"88","author":"Z Bayram-Weston","year":"2012","unstructured":"Bayram-Weston Z, Jones L, Dunnett SB, Brooks SP (2012) Light and electron microscopic characterization of the evolution of cellular pathology in the R6\/1 Huntington\u2019s disease transgenic mice. Brain Res Bull 88:104\u2013112","journal-title":"Brain Res Bull"},{"key":"6_CR5","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.brainresbull.2011.01.010","volume":"88","author":"SP Brooks","year":"2012","unstructured":"Brooks SP, Janghra N, Workman VL et al (2012) Longitudinal analysis of the behavioural phenotype in R6\/1 (C57BL\/6J) Huntington\u2019s disease transgenic mice. Brain Res Bull 88:94\u2013103","journal-title":"Brain Res Bull"},{"key":"6_CR6","doi-asserted-by":"publisher","first-page":"3248","DOI":"10.1523\/JNEUROSCI.19-08-03248.1999","volume":"19","author":"RJ Carter","year":"1999","unstructured":"Carter RJ, Lione LA, Humby T et al (1999) Characterization of progressive motor deficits in mice transgenic for the human Huntington\u2019s disease mutation. J Neurosci 19:3248\u20133257","journal-title":"J Neurosci"},{"key":"6_CR7","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1152\/jn.00762.2011","volume":"107","author":"DM Cummings","year":"2012","unstructured":"Cummings DM, Alaghband Y, Hickey MA et al (2012) A critical window of CAG repeat-length correlates with phenotype severity in the R6\/2 mouse model of Huntington\u2019s disease. J Neurophysiol 107:677\u2013691","journal-title":"J Neurophysiol"},{"key":"6_CR8","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0092-8674(00)80513-9","volume":"90","author":"SW Davies","year":"1997","unstructured":"Davies SW, Turmaine M, Cozens BA et al (1997) Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90:537\u2013548","journal-title":"Cell"},{"key":"6_CR9","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.nbd.2008.10.009","volume":"33","author":"I Dragatsis","year":"2009","unstructured":"Dragatsis I, Goldowitz D, Del Mar N et al (2009) CAG repeat lengths > or = 335 attenuate the phenotype in the R6\/2 Huntington\u2019s disease transgenic mouse. Neurobiol Dis 33:315\u2013330","journal-title":"Neurobiol Dis"},{"key":"6_CR10","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","volume":"87","author":"L Mangiarini","year":"1996","unstructured":"Mangiarini L, Sathasivam K, Seller M et al (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87:493\u2013506","journal-title":"Cell"},{"key":"6_CR11","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.nbd.2009.05.007","volume":"35","author":"L Menalled","year":"2009","unstructured":"Menalled L, El-Khodor BF, Patry M et al (2009) Systematic behavioral evaluation of Huntington\u2019s disease transgenic and knock-in mouse models. Neurobiol Dis 35:319\u2013336","journal-title":"Neurobiol Dis"},{"key":"6_CR12","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.nbd.2008.11.015","volume":"33","author":"AJ Morton","year":"2009","unstructured":"Morton AJ, Glynn D, Leavens W et al (2009) Paradoxical delay in the onset of disease caused by super-long CAG repeat expansions in R6\/2 mice. Neurobiol Dis 33:331\u2013341","journal-title":"Neurobiol Dis"},{"key":"6_CR13","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/hmg\/8.3.397","volume":"8","author":"G Schilling","year":"1999","unstructured":"Schilling G, Becher MW, Sharp AH et al (1999) Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin. Hum Mol Genet 8:397\u2013407","journal-title":"Hum Mol Genet"},{"key":"6_CR14","doi-asserted-by":"crossref","first-page":"9112","DOI":"10.1523\/JNEUROSCI.21-23-09112.2001","volume":"21","author":"GA Laforet","year":"2001","unstructured":"Laforet GA, Sapp E, Chase K et al (2001) Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington\u2019s disease. J Neurosci 21:9112\u20139123","journal-title":"J Neurosci"},{"key":"6_CR15","doi-asserted-by":"crossref","first-page":"6182","DOI":"10.1523\/JNEUROSCI.0857-08.2008","volume":"28","author":"M Gray","year":"2008","unstructured":"Gray M, Shirasaki DI, Cepeda C et al (2008) Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice. J Neurosci 28:6182\u20136195","journal-title":"J Neurosci"},{"key":"6_CR16","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.nbd.2006.12.010","volume":"26","author":"JM Raamsdonk Van","year":"2007","unstructured":"Van Raamsdonk JM, Metzler M, Slow E et al (2007) Phenotypic abnormalities in the YAC128 mouse model of Huntington disease are penetrant on multiple genetic backgrounds and modulated by strain. Neurobiol Dis 26:189\u2013200","journal-title":"Neurobiol Dis"},{"key":"6_CR17","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/hmg\/dds397","volume":"22","author":"AL Southwell","year":"2013","unstructured":"Southwell AL, Warby SC, Carroll JB et al (2013) A fully humanized transgenic mouse model of Huntington disease. Hum Mol Genet 22:18\u201334","journal-title":"Hum Mol Genet"},{"key":"6_CR18","first-page":"1115","volume":"26","author":"AL Southwell","year":"2017","unstructured":"Southwell AL, Skotte NH, Villanueva EB et al (2017) A novel humanized mouse model of Huntington disease for preclinical development of therapeutics targeting mutant huntingtin alleles. Hum Mol Genet 26:1115\u20131132","journal-title":"Hum Mol Genet"},{"key":"6_CR19","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1073\/pnas.1221891110","volume":"110","author":"K Sathasivam","year":"2013","unstructured":"Sathasivam K, Neueder A, Gipson TA et al (2013) Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease. Proc Natl Acad Sci U S A 110:2366\u20132370","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6_CR20","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/s41598-017-01409-9","volume":"7","author":"A Neueder","year":"2017","unstructured":"Neueder A, Landles C, Ghosh R et al (2017) The pathogenic exon 1 HTT protein is produced by incomplete splicing in Huntington\u2019s disease patients. Sci Rep 7:1370","journal-title":"Sci Rep"},{"key":"6_CR21","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/ng0297-197","volume":"15","author":"L Mangiarini","year":"1997","unstructured":"Mangiarini L, Sathasivam K, Mahal A et al (1997) Instability of highly expanded CAG repeats in mice transgenic for the Huntington\u2019s disease mutation. Nat Genet 15:197\u2013200","journal-title":"Nat Genet"},{"key":"6_CR22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1001717","volume":"11","author":"M Mielcarek","year":"2013","unstructured":"Mielcarek M, Landles C, Weiss A et al (2013) HDAC4 reduction: a novel therapeutic strategy to target cytoplasmic huntingtin and ameliorate neurodegeneration. PLoS Biol 11:e1001717","journal-title":"PLoS Biol"},{"key":"6_CR23","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1093\/hmg\/8.7.1227","volume":"8","author":"H Li","year":"1999","unstructured":"Li H, Li S-H, Cheng AL et al (1999) Ultrastructural localization and progressive formation of neuropil aggregates in Huntington\u2019s disease transgenic mice. Hum Mol Genet 8:1227\u20131236","journal-title":"Hum Mol Genet"},{"key":"6_CR24","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/hmg\/ddp467","volume":"19","author":"K Sathasivam","year":"2010","unstructured":"Sathasivam K, Lane A, Legleiter J et\u00a0al (2010) Identical oligomeric and fibrillar structures captured from the brains of R6\/2 and knock-in mouse models of Huntington\u2019s disease. Hum Mol Genet 19:65\u201378","journal-title":"Hum Mol Genet"},{"key":"6_CR25","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/cne.20680","volume":"490","author":"EC Stack","year":"2005","unstructured":"Stack EC, Kubilus JK, Smith K et al (2005) Chronology of behavioral symptoms and neuropathological sequela in R6\/2 Huntington\u2019s disease transgenic mice. J Comp Neurol 490:354\u2013370","journal-title":"J Comp Neurol"},{"key":"6_CR26","doi-asserted-by":"crossref","first-page":"10428","DOI":"10.1523\/JNEUROSCI.19-23-10428.1999","volume":"19","author":"LA Lione","year":"1999","unstructured":"Lione LA, Carter RJ, Hunt MJ et al (1999) Selective discrimination learning impairments in mice expressing the human Huntington\u2019s disease mutation. J Neurosci 19:10428\u201310437","journal-title":"J Neurosci"},{"key":"6_CR27","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.1523\/JNEUROSCI.20-13-05115.2000","volume":"20","author":"KP Murphy","year":"2000","unstructured":"Murphy KP, Carter RJ, Lione LA et al (2000) Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington\u2019s disease mutation. J Neurosci 20:5115\u20135123","journal-title":"J Neurosci"},{"key":"6_CR28","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1523\/JNEUROSCI.23-03-00961.2003","volume":"23","author":"C Cepeda","year":"2003","unstructured":"Cepeda C, Hurst RS, Calvert CR et al (2003) Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington\u2019s disease. J Neurosci 23:961\u2013969","journal-title":"J Neurosci"},{"key":"6_CR29","volume":"8","author":"I Rattray","year":"2013","unstructured":"Rattray I, Smith E, Gale R et al (2013) Correlations of behavioral deficits with brain pathology assessed through longitudinal MRI and histopathology in the R6\/2 mouse model of HD. PLoS One 8:e60012","journal-title":"PLoS One"},{"key":"6_CR30","doi-asserted-by":"crossref","first-page":"6480","DOI":"10.1073\/pnas.95.11.6480","volume":"95","author":"JH Cha","year":"1998","unstructured":"Cha JH, Kosinski CM, Kerner JA et al (1998) Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene. Proc Natl Acad Sci U S A 95:6480\u20136485","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6_CR31","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1093\/hmg\/9.9.1259","volume":"9","author":"R Luthi-Carter","year":"2000","unstructured":"Luthi-Carter R, Strand A, Peters NL et al (2000) Decreased expression of striatal signaling genes in a mouse model of Huntington\u2019s disease. Hum Mol Genet 9:1259\u20131271","journal-title":"Hum Mol Genet"},{"key":"6_CR32","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1750-1326-3-17","volume":"3","author":"CL Benn","year":"2008","unstructured":"Benn CL, Fox H, Bates GP (2008) Optimisation of region-specific reference gene selection and relative gene expression analysis methods for pre-clinical trials of Huntington\u2019s disease. Mol Neurodegener 3:17","journal-title":"Mol Neurodegener"},{"key":"6_CR33","doi-asserted-by":"crossref","first-page":"6809","DOI":"10.1073\/pnas.120166397","volume":"97","author":"JA Bibb","year":"2000","unstructured":"Bibb JA, Yan Z, Svenningsson P, Snyder GL et al (2000) Severe deficiencies in dopamine signaling in presymptomatic Huntington\u2019s disease mice. Proc Natl Acad Sci U S A 97:6809\u20136814","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6_CR34","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1006\/exnr.1999.7327","volume":"162","author":"L Menalled","year":"2000","unstructured":"Menalled L, Zanjani H, MacKenzie L et al (2000) Decrease in striatal enkephalin mRNA in mouse models of Huntington\u2019s disease. Exp Neurol 162:328\u2013342","journal-title":"Exp Neurol"},{"key":"6_CR35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004550","volume":"10","author":"M Mielcarek","year":"2014","unstructured":"Mielcarek M, Inuabasi L, Bondulich MK et al (2014) Dysfunction of the CNS-heart axis in mouse models of Huntington\u2019s disease. PLoS Genet 10:e1004550","journal-title":"PLoS Genet"},{"key":"6_CR36","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1111\/j.1460-9568.2004.03783.x","volume":"20","author":"RR Ribchester","year":"2004","unstructured":"Ribchester RR, Thomson D, Wood NI et al (2004) Progressive abnormalities in skeletal muscle and neuromuscular junctions of transgenic mice expressing the Huntington\u2019s disease mutation. Eur J Neurosci 20:3092\u20133114","journal-title":"Eur J Neurosci"},{"key":"6_CR37","doi-asserted-by":"crossref","first-page":"5820","DOI":"10.1073\/pnas.0501507102","volume":"102","author":"SQ Harper","year":"2005","unstructured":"Harper SQ, Staber PD, He X et al (2005) RNA interference improves motor and neuropathological abnormalities in a Huntington\u2019s disease mouse model. Proc Natl Acad Sci U S A 102:5820\u20135825","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6_CR38","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1093\/hmg\/dds037","volume":"21","author":"MA Pouladi","year":"2012","unstructured":"Pouladi MA, Stanek LM, Xie YY et al (2012) Marked differences in neurochemistry and aggregates despite similar behavioural and neuropathological features of Huntington disease in the full-length BACHD and YAC128 mice. Hum Mol Genet 21:2219\u20132232","journal-title":"Hum Mol Genet"},{"key":"6_CR39","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","volume":"12","author":"EJ Slow","year":"2003","unstructured":"Slow EJ, van Raamsdonk J, Rogers D et al (2003) Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease. Hum Mol Genet 12:1555\u20131567","journal-title":"Hum Mol Genet"},{"key":"6_CR40","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1093\/hmg\/ddi407","volume":"14","author":"JM Raamsdonk Van","year":"2005","unstructured":"Van Raamsdonk JM, Murphy Z, Slow EJ et al (2005) Selective degeneration and nuclear localization of mutant huntingtin in the YAC128 mouse model of Huntington disease. Hum Mol Genet 14:3823\u20133835","journal-title":"Hum Mol Genet"},{"key":"6_CR41","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.brainresbull.2010.05.005","volume":"88","author":"S Brooks","year":"2012","unstructured":"Brooks S, Higgs G, Janghra N et al (2012) Longitudinal analysis of the behavioural phenotype in YAC128 (C57BL\/6J) Huntington\u2019s disease transgenic mice. Brain Res Bull 88:113\u2013120","journal-title":"Brain Res Bull"},{"key":"6_CR42","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.brainresbull.2011.06.008","volume":"88","author":"SP Brooks","year":"2012","unstructured":"Brooks SP, Jones L, Dunnett SB (2012) Longitudinal analyses of operant performance on the serial implicit learning task (SILT) in the YAC128 Huntington\u2019s disease mouse line. Brain Res Bull 88:130\u2013136","journal-title":"Brain Res Bull"},{"key":"6_CR43","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.brainresbull.2011.05.010","volume":"88","author":"SP Brooks","year":"2012","unstructured":"Brooks SP, Janghra N, Higgs GV et al (2012) Selective cognitive impairment in the YAC128 Huntington\u2019s disease mouse. Brain Res Bull 88:121\u2013129","journal-title":"Brain Res Bull"},{"key":"6_CR44","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.brainresbull.2011.05.005","volume":"88","author":"Z Bayram-Weston","year":"2012","unstructured":"Bayram-Weston Z, Jones L, Dunnett SB, Brooks SP (2012) Light and electron microscopic characterization of the evolution of cellular pathology in YAC128 Huntington's disease transgenic mice. Brain Res Bull 88:137\u2013147","journal-title":"Brain Res Bull"},{"key":"6_CR45","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.neuroscience.2008.09.020","volume":"157","author":"J Spampanato","year":"2008","unstructured":"Spampanato J, Gu X, Yang XW, Mody I (2008) Progressive synaptic pathology of motor cortical neurons in a BAC transgenic mouse model of Huntington\u2019s disease. Neuroscience 157:606\u2013620","journal-title":"Neuroscience"},{"key":"6_CR46","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1093\/hmg\/ddt203","volume":"22","author":"S Hult Lundh","year":"2013","unstructured":"Hult Lundh S, Nilsson N, Soylu R et al (2013) Hypothalamic expression of mutant huntingtin contributes to the development of depressive-like behavior in the BAC transgenic mouse model of Huntington\u2019s disease. Hum Mol Genet 22:3485\u20133497","journal-title":"Hum Mol Genet"},{"key":"6_CR47","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1093\/hmg\/ddg352","volume":"12","author":"L Kennedy","year":"2003","unstructured":"Kennedy L, Evans E, Chen CM et al (2003) Dramatic tissue-specific mutation length increases are an early molecular event in Huntington disease pathogenesis. Hum Mol Genet 12:3359\u20133367","journal-title":"Hum Mol Genet"},{"key":"6_CR48","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1093\/hmg\/ddq026","volume":"19","author":"MA Pouladi","year":"2010","unstructured":"Pouladi MA, Xie Y, Skotte NH et al (2010) Full-length huntingtin levels modulate body weight by influencing insulin-like growth factor 1 expression. Hum Mol Genet 19:1528\u20131538","journal-title":"Hum Mol Genet"},{"key":"6_CR49","doi-asserted-by":"crossref","unstructured":"Kudwa AE, Menalled LB, Oakeshott S et al (2013) Increased body weight of the BAC HD transgenic mouse model of Huntington\u2019s disease accounts for some but not all of the observed HD-like motor deficits. PLoS Curr HD 5:0ab4f3645aff523c56ecc8ccbe41a198","DOI":"10.1371\/currents.hd.0ab4f3645aff523c56ecc8ccbe41a198"},{"key":"6_CR50","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/cne.10776","volume":"465","author":"LB Menalled","year":"2003","unstructured":"Menalled LB, Sison JD, Dragatsis I et al (2003) Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington\u2019s disease with 140 CAG repeats. J Comp Neurol 465:11\u201326","journal-title":"J Comp Neurol"},{"key":"6_CR51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050717","volume":"7","author":"T Heikkinen","year":"2012","unstructured":"Heikkinen T, Lehtimaki K, Vartiainen N et al (2012) Characterization of neurophysiological and behavioral changes, MRI brain volumetry and 1H MRS in zQ175 knock-in mouse model of Huntington\u2019s disease. PLoS One 7:e50717","journal-title":"PLoS One"},{"key":"6_CR52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049838","volume":"7","author":"LB Menalled","year":"2012","unstructured":"Menalled LB, Kudwa AE, Miller S et al (2012) Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington\u2019s disease: zQ175. PLoS One 7:e50717","journal-title":"PLoS One"},{"key":"6_CR53","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/hmg\/8.1.115","volume":"8","author":"VC Wheeler","year":"1999","unstructured":"Wheeler VC, Auerbach W, White JK et al (1999) Length-dependent gametic CAG repeat instability in the Huntington\u2019s disease knock-in mouse. Hum Mol Genet 8:115\u2013122","journal-title":"Hum Mol Genet"},{"key":"6_CR54","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/hmg\/9.4.503","volume":"9","author":"VC Wheeler","year":"2000","unstructured":"Wheeler VC, White JK, Gutekunst CA et al (2000) Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice. Hum Mol Genet 9:503\u2013513","journal-title":"Hum Mol Genet"},{"key":"6_CR55","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.bbr.2008.01.020","volume":"189","author":"RC Trueman","year":"2008","unstructured":"Trueman RC, Brooks SP, Jones L, Dunnett SB (2008) Time course of choice reaction time deficits in the Hdh(Q92) knock-in mouse model of Huntington\u2019s disease in the operant Serial Implicit Learning Task (SILT). Behav Brain Res 189:317\u2013324","journal-title":"Behav Brain Res"},{"key":"6_CR56","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/hmg\/10.2.137","volume":"10","author":"CH Lin","year":"2001","unstructured":"Lin CH, Tallaksen-Greene S, Chien WM et al (2001) Neurological abnormalities in a knock-in mouse model of Huntington\u2019s disease. Hum Mol Genet 10:137\u2013144","journal-title":"Hum Mol Genet"},{"key":"6_CR57","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.brainresbull.2006.11.004","volume":"72","author":"B Woodman","year":"2007","unstructured":"Woodman B, Butler R, Landles C et al (2007) The Hdh(Q150\/Q150) knock-in mouse model of HD and the R6\/2 exon 1 model develop comparable and widespread molecular phenotypes. Brain Res Bull 72:83\u201397","journal-title":"Brain Res Bull"},{"key":"6_CR58","doi-asserted-by":"crossref","first-page":"8989","DOI":"10.1523\/JNEUROSCI.1830-07.2007","volume":"27","author":"MY Heng","year":"2007","unstructured":"Heng MY, Tallaksen-Greene SJ, Detloff PJ, Albin RL (2007) Longitudinal evaluation of the Hdh(CAG)150 knock-in murine model of Huntington\u2019s disease. J Neurosci 27:8989\u20138998","journal-title":"J Neurosci"},{"key":"6_CR59","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.4161\/auto.6.8.13617","volume":"6","author":"MY Heng","year":"2010","unstructured":"Heng MY, Detloff PJ, Paulson HL, Albin RL (2010) Early alterations of autophagy in Huntington disease-like mice. Autophagy 6:1206\u20131208","journal-title":"Autophagy"},{"key":"6_CR60","volume-title":"A field guide to working with mouse models of Huntington\u2019s disease","author":"L Menalled","year":"2014","unstructured":"Menalled L, Lutz C, Ramboz S et al (2014) A field guide to working with mouse models of Huntington\u2019s disease. Psychogenics Inc., The Jackson Laboratory, CHDI Foundation, New York"},{"key":"6_CR61","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.brainresbull.2006.02.011","volume":"69","author":"SP Brooks","year":"2006","unstructured":"Brooks SP, Betteridge H, Trueman RC et al (2006) Selective extra-dimensional set shifting deficit in a knock-in mouse model of Huntington\u2019s disease. Brain Res Bull 69:452\u2013457","journal-title":"Brain Res Bull"},{"key":"6_CR62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168556","volume":"12","author":"I Rattray","year":"2017","unstructured":"Rattray I, Smith EJ, Crum WR et al (2017) Correlations of behavioral deficits with brain pathology assessed through longitudinal MRI and histopathology in the HdhQ150\/Q150 mouse model of Huntington\u2019s disease. PLoS One 12:e0168556","journal-title":"PLoS One"},{"issue":"15","key":"6_CR63","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/hmg\/ddm133","volume":"16","author":"A Kuhn","year":"2007","unstructured":"Kuhn A, Goldstein DR, Hodges A et al (2007) Mutant huntingtin\u2019s effects on striatal gene expression in mice recapitulate changes observed in human Huntington\u2019s disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage. Hum Mol Genet 16(15):1845\u20131861","journal-title":"Hum Mol Genet"},{"key":"6_CR64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005021","volume":"11","author":"M Mielcarek","year":"2015","unstructured":"Mielcarek M, Toczek M, Smeets CJ et al (2015) HDAC4-myogenin axis as an important marker of HD-related skeletal muscle atrophy. PLoS Genet 11:e1005021","journal-title":"PLoS Genet"},{"key":"6_CR65","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.brainresbull.2011.03.014","volume":"88","author":"Z Bayram-Weston","year":"2012","unstructured":"Bayram-Weston Z, Torres EM, Jones L et al (2012) Light and electron microscopic characterization of the evolution of cellular pathology in the Hdh(CAG)150 Huntington\u2019s disease knock-in mouse. Brain Res Bull 88:189\u2013198","journal-title":"Brain Res Bull"},{"issue":"4","key":"6_CR66","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.neuroscience.2004.10.037","volume":"131","author":"S.J. Tallaksen-Greene","year":"2005","unstructured":"Tallaksen-Greene SJ, Crouse AB, Hunter JM et al (2005) Neuronal intranuclear inclusions and neuropil aggregates in HdhCAG(150) knock-in mice. Neuroscience 131:843\u2013852","journal-title":"Neuroscience"},{"key":"6_CR67","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1093\/hmg\/ddl125","volume":"15","author":"A Lloret","year":"2006","unstructured":"Lloret A, Dragileva E, Teed A et al (2006) Genetic background modifies nuclear mutant huntingtin accumulation and HD CAG repeat instability in Huntington\u2019s disease knock-in mice. Hum Mol Genet 15:2015\u20132024","journal-title":"Hum Mol Genet"},{"issue":"4","key":"6_CR68","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/(SICI)1097-4547(19991115)58:4<515::AID-JNR5>3.0.CO;2-F","volume":"58","author":"Michael S. Levine","year":"1999","unstructured":"Levine MS, Klapstein GJ, Koppel A et al (1999) Enhanced sensitivity to N-methyl-d-aspartate receptor activation in transgenic and knock-in mouse models of Huntington\u2019s disease. J Neurosci Res 58:515\u2013532","journal-title":"Journal of Neuroscience Research"},{"key":"6_CR69","volume":"11","author":"Q Peng","year":"2016","unstructured":"Peng Q, Wu B, Jiang M et al (2016) Characterization of behavioral, neuropathological, brain metabolic and key molecular changes in zQ175 knock-in mouse model of Huntington\u2019s disease. PLoS One 11:e0148839","journal-title":"PLoS One"},{"key":"6_CR70","doi-asserted-by":"crossref","first-page":"22480","DOI":"10.1073\/pnas.0911503106","volume":"106","author":"J Bradford","year":"2009","unstructured":"Bradford J, Shin JY, Roberts M et al (2009) Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptoms. Proc Natl Acad Sci U S A 106:22480\u201322485","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6_CR71","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1093\/hmg\/ddr040","volume":"20","author":"AT Tebbenkamp","year":"2011","unstructured":"Tebbenkamp AT, Swing D, Tessarollo L, Borchelt DR (2011) Premature death and neurologic abnormalities in transgenic mice expressing a mutant huntingtin exon-2 fragment. Hum Mol Genet 20:1633\u20131642","journal-title":"Hum Mol Genet"},{"key":"6_CR72","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1093\/hmg\/ddr176","volume":"20","author":"AT Tebbenkamp","year":"2011","unstructured":"Tebbenkamp AT, Green C, Xu G et al (2011) Transgenic mice expressing caspase-6-derived N-terminal fragments of mutant huntingtin develop neurologic abnormalities with predominant cytoplasmic inclusion pathology composed largely of a smaller proteolytic derivative. Hum Mol Genet 20:2770\u20132782","journal-title":"Hum Mol Genet"},{"key":"6_CR73","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)80623-6","volume":"101","author":"A Yamamoto","year":"2000","unstructured":"Yamamoto A, Lucas JJ, Hen R (2000) Reversal of neuropathology and motor dysfunction in a conditional model of Huntington\u2019s disease. Cell 101:57\u201366","journal-title":"Cell"},{"key":"6_CR74","doi-asserted-by":"crossref","first-page":"11402","DOI":"10.1073\/pnas.0503634102","volume":"102","author":"EJ Slow","year":"2005","unstructured":"Slow EJ, Graham RK, Osmand AP et al (2005) Absence of behavioral abnormalities and neurodegeneration in vivo despite widespread neuronal huntingtin inclusions. Proc Natl Acad Sci U S A 102:11402\u201311407","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6_CR75","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.neuron.2005.03.025","volume":"46","author":"X Gu","year":"2005","unstructured":"Gu X, Li C, Wei W, Lo V et al (2005) Pathological cell-cell interactions elicited by a neuropathogenic form of mutant Huntingtin contribute to cortical pathogenesis in HD mice. Neuron 46:433\u2013444","journal-title":"Neuron"},{"key":"6_CR76","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.neuron.2009.11.020","volume":"64","author":"X Gu","year":"2009","unstructured":"Gu X, Greiner ER, Mishra R et al (2009) Serines 13 and 16 are critical determinants of full-length human mutant huntingtin induced disease pathogenesis in HD mice. Neuron 64:828\u2013840","journal-title":"Neuron"},{"key":"6_CR77","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.nbd.2005.07.014","volume":"21","author":"Y Tanaka","year":"2006","unstructured":"Tanaka Y, Igarashi S, Nakamura M et al (2006) Progressive phenotype and nuclear accumulation of an amino-terminal cleavage fragment in a transgenic mouse model with inducible expression of full-length mutant huntingtin. Neurobiol Dis 21:381\u2013391","journal-title":"Neurobiol Dis"},{"key":"6_CR78","doi-asserted-by":"crossref","first-page":"8772","DOI":"10.1523\/JNEUROSCI.21-22-08772.2001","volume":"21","author":"E Martin-Aparicio","year":"2001","unstructured":"Martin-Aparicio E, Yamamoto A, Hernandez F et al (2001) Proteasomal-dependent aggregate reversal and absence of cell death in a conditional mouse model of Huntington\u2019s disease. J Neurosci 21:8772\u20138781","journal-title":"J Neurosci"},{"key":"6_CR79","volume-title":"Cortical control of striatal pathogenesis in the Cre\/LoxP conditional BAC transgenic mouse model of Huntington\u2019s disease (BACHD)","author":"M Gray","year":"2008","unstructured":"Gray M, Gu X, Shirasaki DI, Cepeda C et al (2008) Cortical control of striatal pathogenesis in the Cre\/LoxP conditional BAC transgenic mouse model of Huntington\u2019s disease (BACHD). Society for Neuroscience, Washington, DC"},{"key":"6_CR80","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1750-1326-2-8","volume":"2","author":"X Gu","year":"2007","unstructured":"Gu X, Andre VM, Cepeda C et al (2007) Pathological cell-cell interactions are necessary for striatal pathogenesis in a conditional mouse model of Huntington\u2019s disease. Mol Neurodegener 2:8","journal-title":"Mol Neurodegener"},{"key":"6_CR81","volume":"3","author":"SH Kim","year":"2011","unstructured":"Kim SH, Thomas CA, Andre VM et al (2011) Forebrain striatal-specific expression of mutant huntingtin protein in vivo induces cell-autonomous age-dependent alterations in sensitivity to excitotoxicity and mitochondrial function. ASN Neuro 3:e00060","journal-title":"ASN Neuro"},{"key":"6_CR82","doi-asserted-by":"crossref","first-page":"10653","DOI":"10.1074\/jbc.M109.083287","volume":"285","author":"J Bradford","year":"2010","unstructured":"Bradford J, Shin JY, Roberts M et al (2010) Mutant huntingtin in glial cells exacerbates neurological symptoms of Huntington disease mice. J Biol Chem 285:10653\u201310661","journal-title":"J Biol Chem"},{"key":"6_CR83","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0092-8674(00)81782-1","volume":"95","author":"F Saudou","year":"1998","unstructured":"Saudou F, Finkbeiner S, Devys D, Greenberg ME (1998) Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 95:55\u201366","journal-title":"Cell"},{"key":"6_CR84","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1093\/hmg\/ddh175","volume":"13","author":"G Schilling","year":"2004","unstructured":"Schilling G, Savonenko AV, Klevytska A et al (2004) Nuclear-targeting of mutant huntingtin fragments produces Huntington\u2019s disease-like phenotypes in transgenic mice. Hum Mol Genet 13:1599\u20131610","journal-title":"Hum Mol Genet"},{"key":"6_CR85","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1093\/hmg\/ddi340","volume":"14","author":"CL Benn","year":"2005","unstructured":"Benn CL, Landles C, Li H et al (2005) Contribution of nuclear and extranuclear polyQ to neurological phenotypes in mouse models of Huntington\u2019s disease. Hum Mol Genet 14:3065\u20133078","journal-title":"Hum Mol Genet"},{"key":"6_CR86","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/ng1503","volume":"37","author":"J Cornett","year":"2005","unstructured":"Cornett J, Cao F, Wang CE et al (2005) Polyglutamine expansion of huntingtin impairs its nuclear export. Nat Genet 37:198\u2013204","journal-title":"Nat Genet"},{"key":"6_CR87","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.neuron.2015.01.008","volume":"85","author":"X Gu","year":"2015","unstructured":"Gu X, Cantle JP, Greiner ER et al (2015) N17 modifies mutant Huntingtin nuclear pathogenesis and severity of disease in HD BAC transgenic mice. Neuron 85:726\u2013741","journal-title":"Neuron"},{"key":"6_CR88","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.cell.2006.04.026","volume":"125","author":"RK Graham","year":"2006","unstructured":"Graham RK, Deng Y, Slow EJ et al (2006) Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin. Cell 125:1179\u20131191","journal-title":"Cell"},{"key":"6_CR89","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1523\/JNEUROSCI.1305-11.2012","volume":"32","author":"E Waldron-Roby","year":"2012","unstructured":"Waldron-Roby E, Ratovitski T, Wang X (2012) Transgenic mouse model expressing the caspase 6 fragment of mutant huntingtin. J Neurosci 32:183\u2013193","journal-title":"J Neurosci"},{"key":"6_CR90","doi-asserted-by":"crossref","first-page":"7454","DOI":"10.1523\/JNEUROSCI.6379-11.2012","volume":"32","author":"J Gafni","year":"2012","unstructured":"Gafni J, Papanikolaou T, Degiacomo F et al (2012) Caspase-6 activity in a BACHD mouse modulates steady-state levels of mutant huntingtin protein but is not necessary for production of a 586 amino acid proteolytic fragment. J Neurosci 32:7454\u20137465","journal-title":"J Neurosci"},{"key":"6_CR91","first-page":"e4fd085bfc9973","volume":"4","author":"Christian Landles","year":"2012","unstructured":"Landles C, Weiss A, Franklin S et al (2012) Caspase-6 does not contribute to the proteolysis of mutant huntingtin in the HdhQ150 knock-in mouse model of Huntington\u2019s disease. PLoS Curr HD 4:e4fd085bfc9973","journal-title":"PLoS Currents"},{"key":"6_CR92","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1093\/hmg\/ddn175","volume":"17","author":"CE Wang","year":"2008","unstructured":"Wang CE, Tydlacka S, Orr AL et al (2008) Accumulation of N-terminal mutant huntingtin in mouse and monkey models implicated as a pathogenic mechanism in Huntington\u2019s disease. Hum Mol Genet 17:2738\u20132751","journal-title":"Hum Mol Genet"},{"key":"6_CR93","doi-asserted-by":"crossref","first-page":"19287","DOI":"10.1074\/jbc.M114.623561","volume":"290","author":"R O\u2019Brien","year":"2015","unstructured":"O\u2019Brien R, DeGiacomo F, Holcomb J et\u00a0al (2015) Integration-independent transgenic Huntington disease fragment mouse models reveal distinct phenotypes and life span in vivo. J Biol Chem 290:19287\u201319306","journal-title":"J Biol Chem"},{"key":"6_CR94","volume":"6","author":"S Zheng","year":"2010","unstructured":"Zheng S, Clabough EB, Sarkar S et al (2010) Deletion of the huntingtin polyglutamine stretch enhances neuronal autophagy and longevity in mice. PLoS Genet 6:e1000838","journal-title":"PLoS Genet"},{"key":"6_CR95","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3233\/JHD-160231","volume":"6","author":"EA Andre","year":"2017","unstructured":"Andre EA, Braatz EM, Liu JP, Zeitlin SO (2017) Generation and characterization of knock-in mouse models expressing versions of huntingtin with either an N17 or a combined polyQ and proline-rich region deletion. J Huntingtons Dis 6:47\u201362","journal-title":"J Huntingtons Dis"},{"key":"6_CR96","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1083\/jcb.200909067","volume":"187","author":"LM Thompson","year":"2009","unstructured":"Thompson LM, Aiken CT, Kaltenbach LS et al (2009) IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosome. J Cell Biol 187:1083\u20131099","journal-title":"J Cell Biol"},{"key":"6_CR97","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s10162-007-0098-3","volume":"8","author":"JR Ison","year":"2007","unstructured":"Ison JR, Allen PD, O\u2019Neill WE (2007) Age-related hearing loss in C57BL\/6J mice has both frequency-specific and non-frequency-specific components that produce a hyperacusis-like exaggeration of the acoustic startle reflex. J Assoc Res Otolaryngol 8:539\u2013550","journal-title":"J Assoc Res Otolaryngol"},{"key":"6_CR98","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0896-6273(00)80958-7","volume":"19","author":"AJ Silva","year":"1997","unstructured":"Silva AJ, Simpson EM, Takahashi JS et al (1997) Mutant mice and neuroscience: recommendations concerning genetic background. Neuron 19:755\u2013759","journal-title":"Neuron"},{"key":"6_CR99","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1037\/a0026033","volume":"125","author":"SJ Farley","year":"2011","unstructured":"Farley SJ, McKay BM, Disterhoft JF, Weiss C (2011) Reevaluating hippocampus-dependent learning in FVB\/N mice. Behav Neurosci 125:871","journal-title":"Behav Neurosci"},{"key":"6_CR100","first-page":"RRN1303","volume":"4","author":"Liliana Menalled","year":"2012","unstructured":"Menalled L, El-Khodor BF, Hornberger M et al (2012) Effect of the rd1 mutation on motor performance in R6\/2 and wild type mice. PLoS Curr HD 4:RRN1303","journal-title":"PLoS Currents"},{"key":"6_CR101","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/35008142","volume":"404","author":"A Dellen van","year":"2000","unstructured":"van Dellen A, Blakemore C, Deacon R et al (2000) Delaying the onset of Huntington\u2019s in mice. Nature 404:721\u2013722","journal-title":"Nature"},{"key":"6_CR102","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/35044558","volume":"1","author":"H Praag van","year":"2000","unstructured":"van Praag H, Kempermann G, Gage FH (2000) Neural consequences of enviromental enrichment. Nat Rev Neurosci 1:191\u2013198","journal-title":"Nat Rev Neurosci"},{"key":"6_CR103","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/ana.10094","volume":"51","author":"E Hockly","year":"2002","unstructured":"Hockly E, Cordery PM, Woodman B et al (2002) Environmental enrichment slows disease progression in R61\/2 Huntington\u2019s disease mice. Ann Neurol 51:235\u2013242","journal-title":"Ann Neurol"},{"key":"6_CR104","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/brb3.235","volume":"4","author":"EA Skillings","year":"2014","unstructured":"Skillings EA, Wood NI, Morton AJ (2014) Beneficial effects of environmental enrichment and food entrainment in the R6\/2 mouse model of Huntington\u2019s disease. Brain Behav 4:675\u2013686","journal-title":"Brain Behav"},{"key":"6_CR105","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/1531-8257(200009)15:5<925::AID-MDS1025>3.0.CO;2-Z","volume":"15","author":"RJ Carter","year":"2000","unstructured":"Carter RJ, Hunt MJ, Morton AJ (2000) Environmental stimulation increases survival in mice transgenic for exon 1 of the Huntington\u2019s disease gene. Mov Disord 15:925\u2013937","journal-title":"Mov Disord"}],"container-title":["Methods in Molecular Biology","Huntington\u2019s Disease"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-7825-0_6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T18:26:08Z","timestamp":1571423168000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-7825-0_6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9781493978243","9781493978250"],"references-count":105,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-7825-0_6","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}